An electrokinetic supercharging approach for the enantiodetermination of cathinones in urine samples by capillary electrophoresis

2020 ◽  
Vol 158 ◽  
pp. 105300
Author(s):  
Albert Pérez-Alcaraz ◽  
Francesc Borrull ◽  
Carme Aguilar ◽  
Marta Calull
2015 ◽  
Vol 7 (5) ◽  
pp. 2012-2019 ◽  
Author(s):  
Jafar Abolhasani ◽  
Hamid Reza Jafariyan ◽  
Mohammad Mahdi khataei ◽  
Rahim Hosseinzadeh-khanmiri ◽  
Ebrahim Ghorbani-kalhor ◽  
...  

A simple method was developed for the separation and determination of citalopram enantiomers in urine samples.


Molecules ◽  
2019 ◽  
Vol 24 (18) ◽  
pp. 3345 ◽  
Author(s):  
Juraj Piestansky ◽  
Dominika Olesova ◽  
Jaroslav Galba ◽  
Katarina Marakova ◽  
Vojtech Parrak ◽  
...  

Urine represents a convenient biofluid for metabolomic studies due to its noninvasive collection and richness in metabolites. Here, amino acids are valuable biomarkers for their ability to reflect imbalances of different biochemical pathways. An impact of amino acids on pathology, prognosis and therapy of various diseases, including inflammatory bowel disease (IBD), is therefore the subject of current clinical research. This work is aimed to develop a capillary electrophoresis-tandem mass spectrometry (CE-MS/MS) method for the quantification of the 20 proteinogenic amino acids in human urine samples obtained from patients suffering from IBD and treated with thiopurines. The optimized CE-MS/MS method, with minimum sample preparation (just “dilute and shoot”), exhibited excellent linearity for all the analytes (coefficients of determination were higher than 0.99), with inter-day and intra-day precision yielding relative standard deviations in the range of 0.91–15.12% and with accuracy yielding relative errors in the range of 85.47–112.46%. Total analysis time, an important parameter for the sample throughput demanded in routine practice, was shorter in ca. 17% when compared to established CE-MS methods. Favorable performance of the proposed CE-MS/MS method was also confirmed by the comparison with corresponding ultra-high performance liquid chromatography-mass spectrometry (UHPLC-MS) method. Consistent data for the investigated amino acid metabolome were obtained using both methods. For the first time, the amino acid profiling by CE-MS approach was applied on the clinical IBD samples. Here, significant differences observed in the concentration levels of some amino acids between IBD patients undergoing thiopurine treatment and healthy volunteers could result from the simultaneous action of the disease and the corresponding therapy. These findings indicate that amino acids analysis could be a valuable tool for the study of mechanism of the IBD treatment by thiopurines.


2013 ◽  
Vol 935 ◽  
pp. 32-35 ◽  
Author(s):  
Lin Song ◽  
Wanchen Li ◽  
Guoxia Li ◽  
Dianjun Wei ◽  
Peng Ge ◽  
...  

2007 ◽  
Vol 1171 (1-2) ◽  
pp. 140-143 ◽  
Author(s):  
Ana Carolina O. Costa ◽  
José Luiz da Costa ◽  
Fernando G. Tonin ◽  
Marina F.M. Tavares ◽  
Gustavo Amadeu Micke

Metabolites ◽  
2021 ◽  
Vol 11 (10) ◽  
pp. 671
Author(s):  
Rintaro Saito ◽  
Akiyoshi Hirayama ◽  
Arisa Akiba ◽  
Yushi Kamei ◽  
Yuyu Kato ◽  
...  

Acute kidney injury (AKI) is defined as a rapid decline in kidney function. The associated syndromes may lead to increased morbidity and mortality, but its early detection remains difficult. Using capillary electrophoresis time-of-flight mass spectrometry (CE-TOFMS), we analyzed the urinary metabolomic profile of patients admitted to the intensive care unit (ICU) after invasive surgery. Urine samples were collected at six time points: before surgery, at ICU admission and 6, 12, 24 and 48 h after. First, urine samples from 61 initial patients (non-AKI: 23, mild AKI: 24, severe AKI: 14) were measured, followed by the measurement of urine samples from 60 additional patients (non-AKI: 40, mild AKI: 20). Glycine and ethanolamine were decreased in patients with AKI compared with non-AKI patients at 6–24 h in the two groups. The linear statistical model constructed at each time point by machine learning achieved the best performance at 24 h (median AUC: 89%, cross-validated) for the 1st group. When cross-validated between the two groups, the AUC showed the best value of 70% at 12 h. These results identified metabolites and time points that show patterns specific to subjects who develop AKI, paving the way for the development of better biomarkers.


Sign in / Sign up

Export Citation Format

Share Document